Chad Toledo, Ph.D., is currently a Senior Principal Scientist at Pfizer, where they lead projects focused on identifying oncology therapeutic targets and enhancing cancer treatment efficacy. Previously, they served as a Senior Scientist at Pfizer and a Principal Scientist at Nurix, Inc., where they specialized in target discovery and validation in oncology and immune-oncology. Chad earned their Ph.D. in Molecular and Cellular Biology from the University of Washington, where they discovered novel therapeutic targets for glioblastoma multiforme during their graduate research. Their extensive experience in cancer biology and cutting-edge genetic technologies is complemented by a bachelor's degree in Genetics, Cell Biology, and Development from the University of Minnesota-Twin Cities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices